Joel Greenblatt's NUVB Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 182,152 shares of Nuvation Bio Inc. (NUVB) worth $1.03 M, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 4 quarters.
Based on 13F filings, Joel Greenblatt has maintained this position in NUVB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2026, adding 182,152 shares. Largest reduction occurred in Q1 2026, reducing 31,269 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Nuvation Bio (NUVB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Nuvation Bio (NUVB) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +182,152 | New Buy | 182,152 | $5.68 |
| Q1 2026 | -31,269 | Sold Out | 0 | $0.00 |
| Q4 2025 | +14,204 | Add 83.23% | 31,269 | $8.96 |
| Q3 2025 | +17,065 | New Buy | 17,065 | $3.70 |
Joel Greenblatt's Nuvation Bio Investment FAQs
Joel Greenblatt first purchased Nuvation Bio Inc. (NUVB) in Q3 2025, acquiring 17,065 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Nuvation Bio Inc. (NUVB) for 4 quarters since Q3 2025.
Joel Greenblatt's largest addition to Nuvation Bio Inc. (NUVB) was in Q2 2026, adding 182,152 shares worth $1.03 M.
According to the latest 13F filing for Q2 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 182,152 shares of Nuvation Bio Inc. (NUVB), valued at approximately $1.03 M.
As of the Q2 2026 filing, Nuvation Bio Inc. (NUVB) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Nuvation Bio Inc. (NUVB) was 182,152 shares, as reported at the end of Q2 2026.